Performance of <scp>HPV E6</scp> / <scp>E7 mRNA</scp> assay as primary screening test: Results from the <scp>NTCC2</scp> trial-Reference-Cited by-同舟云学术

Performance of HPV E6 / E7 mRNA assay as primary screening test: Results from the NTCC2 trial

Published:2022-06-07 Issue:7 Volume:151 Page:1047-1058
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Giorgi Rossi Paolo¹^ORCID,Ronco Guglielmo²^ORCID,Mancuso Pamela¹^ORCID,Carozzi Francesca³,Allia Elena⁴,Bisanzi Simonetta³,Gillio‐Tos Anna⁴,De Marco Laura⁴⁵,Rizzolo Raffaella²,Gustinucci Daniela⁶,Del Mistro Annarosa⁷,Frayle Helena⁷,Confortini Massimo³,Iossa Anna⁸,Cesarini Elena⁶,Bulletti Simonetta⁶,Passamonti Basilio⁶,Gori Silvia⁷,Toniolo Laura⁹,Barca Alessandra¹⁰,Bonvicini Laura¹,Venturelli Francesco¹,Benevolo Maria¹¹^ORCID,

Affiliation:

1. Epidemiology Unit Azienda Unità Sanitaria Locale—IRCCS di Reggio Emilia Reggio Emilia Italy

2. Centre for Cancer Epidemiology and Prevention (CPO) Turin Italy

3. Institute for Cancer Research, Prevention and Clinical Network (ISPRO) Florence Italy

4. Centre for Cervical Cancer Screening City of Health and Science Hospital Turin Italy

5. Unit of Cancer Epidemiology and Centre for Cancer Prevention (CPO) City of Health and Science Hospital Turin Italy

6. Laboratorio Unico di Screening, USL Umbria 1 Perugia Italy

7. Istituto Oncologico Veneto IOV—IRCCS Padua Italy

8. ISPRO Oncological Network Prevention and Research Institute, Screening Unit Florence Italy

9. ULSS6 Euganea Padua Italy

10. Assessorato alla Salute Rome Italy

11. IRCCS—Regina Elena National Cancer Institute Rome Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34120

Reference41 articles.

1. WHO.WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization. 2013.https://www.who.int/reproductivehealth/publications/cancers/screening_and_treatment_of_precancerous_lesions/en/. Accessed June 27 2019.

2. Screening for Cervical Cancer

3. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

4. Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The level of expression of HPV16 early transcripts is not associated with the natural history of cervical lesions;Journal of Medical Virology;2024-09

2. The Mechanism of HPV-mediated DNA Methylation in the Promoter Region of Long-chain Non-coding RNA MAGI2-AS3 in the Occurrence and Development of Cervical Cancer;Clinical and Experimental Obstetrics & Gynecology;2024-06-18

3. Perceptions towards using Artificial Intelligence and Technology for Asthma Attack Risk Prediction: A Qualitative Exploration of Māori Views (Preprint);JMIR Formative Research;2024-04-23

4. Families’ Experiences with Family-focused Web-based Interventions for Improving Health: A Qualitative Systematic Literature Review (Preprint);2024-03-25

5. Patient-Centric Approach to Personalized Electronic Medical Records via QR code in Japan (Preprint);2024-02-14